Perioral dermatitis is a type of rash which affects the area around the mouth and causes inflammation. The rash will extend up the nose or even into the eyes. The common symptom of this condition is a scaly or red bumpy rash. Lesions on darker skin can be hyperpigmented or brown. Antibiotics can be advantageous for a few weeks, whether oral or topically. Azelaic acid is a prescription-only topical medication. When treatment is disturbed, the problem may reoccur, but the same therapy can be restarted as needed.
This report aims to provide a comprehensive study of the global market for Perioral Dermatitis Treatment. Report Highlights:
(1) Global Perioral Dermatitis Treatment market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Perioral Dermatitis Treatment market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Perioral Dermatitis Treatment market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Perioral Dermatitis Treatment segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Perioral Dermatitis Treatment segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Perioral Dermatitis Treatment, capacity, production and trends.
(7) Perioral Dermatitis Treatment industry supply chain, upstream, midstream and downstream analysis.
According to latest study, the global market for Perioral Dermatitis Treatment should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Perioral Dermatitis Treatment market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Perioral Dermatitis Treatment market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Oral segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Retail Pharmacy has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Perioral Dermatitis Treatment include Novartis AG, AstraZeneca, Merck & Co., Inc, Sumitomo Corporation, LEO Pharma A/S, Cipla Inc, Lilly, Bayer AG and Abbott, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Oral
Injection
External Use
Market segment by application, can be divided into
Retail Pharmacy
Online Pharmacies
Other
Market segment by players, this report covers
Novartis AG
AstraZeneca
Merck & Co., Inc
Sumitomo Corporation
LEO Pharma A/S
Cipla Inc
Lilly
Bayer AG
Abbott
Pfizer Inc
GSK plc
Johnson & Johnson Private Limited
Teva Pharmaceutical Industries Ltd
Sun Pharmaceutical Industries Ltd
Aurobindo Pharma
Lupin
Bausch Health Companies Inc
F. Hoffmann-La Roche Ltd
Mylan N.V
1 Market Overview
1.1 Perioral Dermatitis Treatment Definition
1.2 Global Perioral Dermatitis Treatment Market Size and Forecast
1.2.1 By Revenue, Global Perioral Dermatitis Treatment Market Size, 2018-2029
1.2.2 By Sales Volume, Global Perioral Dermatitis Treatment Market Size, 2018-2029
1.2.3 Global Perioral Dermatitis Treatment Price Trend, 2018-2029
1.3 China Perioral Dermatitis Treatment Market Size and Forecast
1.3.1 By Revenue, China Perioral Dermatitis Treatment Market Size, 2018-2029
1.3.2 By Sales Volume, China Perioral Dermatitis Treatment Market Size, 2018-2029
1.3.3 China Perioral Dermatitis Treatment Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Perioral Dermatitis Treatment Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Perioral Dermatitis Treatment Share in Global Market, 2018-2029
1.4.3 Perioral Dermatitis Treatment Market Size: China VS Global, 2018-2029
1.5 Perioral Dermatitis Treatment Market Dynamics
1.5.1 Perioral Dermatitis Treatment Market Drivers
1.5.2 Perioral Dermatitis Treatment Market Restraints
1.5.3 Perioral Dermatitis Treatment Industry Trends
1.5.4 Perioral Dermatitis Treatment Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Perioral Dermatitis Treatment Revenue by Company, 2018-2023
2.2 Global Perioral Dermatitis Treatment Sales Volume by Company, 2018-2023
2.3 Global Perioral Dermatitis Treatment Price by Company, 2018-2023
2.4 Global Perioral Dermatitis Treatment Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Perioral Dermatitis Treatment Concentration Ratio
2.6 Global Perioral Dermatitis Treatment Mergers & Acquisitions, Expansion Plans
2.7 Global Perioral Dermatitis Treatment Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Perioral Dermatitis Treatment Revenue by Company, 2018-2023
3.2 China Perioral Dermatitis Treatment Sales Volume by Company, 2018-2023
3.3 China Perioral Dermatitis Treatment Perioral Dermatitis Treatment Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Perioral Dermatitis Treatment Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Perioral Dermatitis Treatment Domestic VS Export
3.6 China Market, Perioral Dermatitis Treatment Import & Export
3.6.1 China Market, Perioral Dermatitis Treatment Import & Export, 2018-2029
3.6.2 China Perioral Dermatitis Treatment Import & Export Trends
3.6.3 Main Sources of China Perioral Dermatitis Treatment Import
3.6.4 Export Destination of China Perioral Dermatitis Treatment
4 Perioral Dermatitis Treatment Production by Region
4.1 Global Perioral Dermatitis Treatment Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Perioral Dermatitis Treatment Manufacturers
4.3 Global Major Manufacturers, Perioral Dermatitis Treatment Capacity Expansion and Future Plans
4.4 Global Perioral Dermatitis Treatment Capacity by Region
4.5 Global Perioral Dermatitis Treatment Production by Region
4.5.1 Global Perioral Dermatitis Treatment Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Perioral Dermatitis Treatment Production by Region, 2018-2023
4.5.3 Global Perioral Dermatitis Treatment Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Perioral Dermatitis Treatment Industry Chain
5.2 Perioral Dermatitis Treatment Upstream Analysis
5.2.1 Perioral Dermatitis Treatment Core Raw Materials
5.2.2 Main Manufacturers of Perioral Dermatitis Treatment Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Perioral Dermatitis Treatment Production Mode
5.6 Perioral Dermatitis Treatment Procurement Model
5.7 Perioral Dermatitis Treatment Industry Sales Model and Sales Channels
5.7.1 Perioral Dermatitis Treatment Sales Model
5.7.2 Perioral Dermatitis Treatment Typical Distributors
6 Sights by Type
6.1 Perioral Dermatitis Treatment Classification
6.1.1 Oral
6.1.2 Injection
6.1.3 External Use
6.2 By Type, Global Perioral Dermatitis Treatment Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Perioral Dermatitis Treatment Revenue, 2018-2029
6.4 By Type, Global Perioral Dermatitis Treatment Sales Volume, 2018-2029
6.5 By Type, Global Perioral Dermatitis Treatment Price, 2018-2029
7 Sights by Application
7.1 Perioral Dermatitis Treatment Segment by Application
7.1.1 Retail Pharmacy
7.1.2 Online Pharmacies
7.1.3 Other
7.2 By Application, Global Perioral Dermatitis Treatment Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Perioral Dermatitis Treatment Revenue, 2018-2029
7.4 By Application, Global Perioral Dermatitis Treatment Sales Volume, 2018-2029
7.5 By Application, Global Perioral Dermatitis Treatment Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Perioral Dermatitis Treatment Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Perioral Dermatitis Treatment Revenue, 2018-2029
8.3 By Region, Global Perioral Dermatitis Treatment Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Perioral Dermatitis Treatment Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Perioral Dermatitis Treatment Market Size Market Share
8.5 Europe
8.5.1 Europe Perioral Dermatitis Treatment Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Perioral Dermatitis Treatment Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Perioral Dermatitis Treatment Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Perioral Dermatitis Treatment Market Size Market Share
8.7 South America
8.7.1 South America Perioral Dermatitis Treatment Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Perioral Dermatitis Treatment Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Perioral Dermatitis Treatment Market Size & CAGR,2018 VS 2022 VS 2029
9.2 By Country, Global Perioral Dermatitis Treatment Revenue, 2018-2029
9.3 By Country, Global Perioral Dermatitis Treatment Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Perioral Dermatitis Treatment Market Size, 2018-2029
9.4.2 By Company, U.S. Perioral Dermatitis Treatment Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Perioral Dermatitis Treatment Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Perioral Dermatitis Treatment Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Perioral Dermatitis Treatment Market Size, 2018-2029
9.5.2 By Company, Europe Perioral Dermatitis Treatment Sales Volume Market Share, 2022
9.5.3 By Type, Europe Perioral Dermatitis Treatment Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Perioral Dermatitis Treatment Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Perioral Dermatitis Treatment Market Size, 2018-2029
9.6.2 By Company, China Perioral Dermatitis Treatment Sales Volume Market Share, 2022
9.6.3 By Type, China Perioral Dermatitis Treatment Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Perioral Dermatitis Treatment Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Perioral Dermatitis Treatment Market Size, 2018-2029
9.7.2 By Company, Japan Perioral Dermatitis Treatment Sales Volume Market Share, 2022
9.7.3 By Type, Japan Perioral Dermatitis Treatment Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Perioral Dermatitis Treatment Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Perioral Dermatitis Treatment Market Size, 2018-2029
9.8.2 By Company, South Korea Perioral Dermatitis Treatment Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Perioral Dermatitis Treatment Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Perioral Dermatitis Treatment Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Perioral Dermatitis Treatment Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Perioral Dermatitis Treatment Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Perioral Dermatitis Treatment Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Perioral Dermatitis Treatment Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Perioral Dermatitis Treatment Market Size, 2018-2029
9.10.2 By Company, India Perioral Dermatitis Treatment Sales Volume Market Share, 2022
9.10.3 By Type, India Perioral Dermatitis Treatment Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Perioral Dermatitis Treatment Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Perioral Dermatitis Treatment Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Perioral Dermatitis Treatment Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Perioral Dermatitis Treatment Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Perioral Dermatitis Treatment Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Novartis AG
10.1.1 Novartis AG Company Information, Head Office, Market Area and Industry Position
10.1.2 Novartis AG Perioral Dermatitis Treatment Models, Specifications and Application
10.1.3 Novartis AG Perioral Dermatitis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Novartis AG Company Profile and Main Business
10.1.5 Novartis AG Recent Developments
10.2 AstraZeneca
10.2.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position
10.2.2 AstraZeneca Perioral Dermatitis Treatment Models, Specifications and Application
10.2.3 AstraZeneca Perioral Dermatitis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 AstraZeneca Company Profile and Main Business
10.2.5 AstraZeneca Recent Developments
10.3 Merck & Co., Inc
10.3.1 Merck & Co., Inc Company Information, Head Office, Market Area and Industry Position
10.3.2 Merck & Co., Inc Perioral Dermatitis Treatment Models, Specifications and Application
10.3.3 Merck & Co., Inc Perioral Dermatitis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Merck & Co., Inc Company Profile and Main Business
10.3.5 Merck & Co., Inc Recent Developments
10.4 Sumitomo Corporation
10.4.1 Sumitomo Corporation Company Information, Head Office, Market Area and Industry Position
10.4.2 Sumitomo Corporation Perioral Dermatitis Treatment Models, Specifications and Application
10.4.3 Sumitomo Corporation Perioral Dermatitis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Sumitomo Corporation Company Profile and Main Business
10.4.5 Sumitomo Corporation Recent Developments
10.5 LEO Pharma A/S
10.5.1 LEO Pharma A/S Company Information, Head Office, Market Area and Industry Position
10.5.2 LEO Pharma A/S Perioral Dermatitis Treatment Models, Specifications and Application
10.5.3 LEO Pharma A/S Perioral Dermatitis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 LEO Pharma A/S Company Profile and Main Business
10.5.5 LEO Pharma A/S Recent Developments
10.6 Cipla Inc
10.6.1 Cipla Inc Company Information, Head Office, Market Area and Industry Position
10.6.2 Cipla Inc Perioral Dermatitis Treatment Models, Specifications and Application
10.6.3 Cipla Inc Perioral Dermatitis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Cipla Inc Company Profile and Main Business
10.6.5 Cipla Inc Recent Developments
10.7 Lilly
10.7.1 Lilly Company Information, Head Office, Market Area and Industry Position
10.7.2 Lilly Perioral Dermatitis Treatment Models, Specifications and Application
10.7.3 Lilly Perioral Dermatitis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Lilly Company Profile and Main Business
10.7.5 Lilly Recent Developments
10.8 Bayer AG
10.8.1 Bayer AG Company Information, Head Office, Market Area and Industry Position
10.8.2 Bayer AG Perioral Dermatitis Treatment Models, Specifications and Application
10.8.3 Bayer AG Perioral Dermatitis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Bayer AG Company Profile and Main Business
10.8.5 Bayer AG Recent Developments
10.9 Abbott
10.9.1 Abbott Company Information, Head Office, Market Area and Industry Position
10.9.2 Abbott Perioral Dermatitis Treatment Models, Specifications and Application
10.9.3 Abbott Perioral Dermatitis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Abbott Company Profile and Main Business
10.9.5 Abbott Recent Developments
10.10 Pfizer Inc
10.10.1 Pfizer Inc Company Information, Head Office, Market Area and Industry Position
10.10.2 Pfizer Inc Perioral Dermatitis Treatment Models, Specifications and Application
10.10.3 Pfizer Inc Perioral Dermatitis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Pfizer Inc Company Profile and Main Business
10.10.5 Pfizer Inc Recent Developments
10.11 GSK plc
10.11.1 GSK plc Company Information, Head Office, Market Area and Industry Position
10.11.2 GSK plc Perioral Dermatitis Treatment Models, Specifications and Application
10.11.3 GSK plc Perioral Dermatitis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 GSK plc Company Profile and Main Business
10.11.5 GSK plc Recent Developments
10.12 Johnson & Johnson Private Limited
10.12.1 Johnson & Johnson Private Limited Company Information, Head Office, Market Area and Industry Position
10.12.2 Johnson & Johnson Private Limited Perioral Dermatitis Treatment Models, Specifications and Application
10.12.3 Johnson & Johnson Private Limited Perioral Dermatitis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Johnson & Johnson Private Limited Company Profile and Main Business
10.12.5 Johnson & Johnson Private Limited Recent Developments
10.13 Teva Pharmaceutical Industries Ltd
10.13.1 Teva Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position
10.13.2 Teva Pharmaceutical Industries Ltd Perioral Dermatitis Treatment Models, Specifications and Application
10.13.3 Teva Pharmaceutical Industries Ltd Perioral Dermatitis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Teva Pharmaceutical Industries Ltd Company Profile and Main Business
10.13.5 Teva Pharmaceutical Industries Ltd Recent Developments
10.14 Sun Pharmaceutical Industries Ltd
10.14.1 Sun Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position
10.14.2 Sun Pharmaceutical Industries Ltd Perioral Dermatitis Treatment Models, Specifications and Application
10.14.3 Sun Pharmaceutical Industries Ltd Perioral Dermatitis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Sun Pharmaceutical Industries Ltd Company Profile and Main Business
10.14.5 Sun Pharmaceutical Industries Ltd Recent Developments
10.15 Aurobindo Pharma
10.15.1 Aurobindo Pharma Company Information, Head Office, Market Area and Industry Position
10.15.2 Aurobindo Pharma Perioral Dermatitis Treatment Models, Specifications and Application
10.15.3 Aurobindo Pharma Perioral Dermatitis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Aurobindo Pharma Company Profile and Main Business
10.15.5 Aurobindo Pharma Recent Developments
10.16 Lupin
10.16.1 Lupin Company Information, Head Office, Market Area and Industry Position
10.16.2 Lupin Perioral Dermatitis Treatment Models, Specifications and Application
10.16.3 Lupin Perioral Dermatitis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.16.4 Lupin Company Profile and Main Business
10.16.5 Lupin Recent Developments
10.17 Bausch Health Companies Inc
10.17.1 Bausch Health Companies Inc Company Information, Head Office, Market Area and Industry Position
10.17.2 Bausch Health Companies Inc Perioral Dermatitis Treatment Models, Specifications and Application
10.17.3 Bausch Health Companies Inc Perioral Dermatitis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.17.4 Bausch Health Companies Inc Company Profile and Main Business
10.17.5 Bausch Health Companies Inc Recent Developments
10.18 F. Hoffmann-La Roche Ltd
10.18.1 F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area and Industry Position
10.18.2 F. Hoffmann-La Roche Ltd Perioral Dermatitis Treatment Models, Specifications and Application
10.18.3 F. Hoffmann-La Roche Ltd Perioral Dermatitis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.18.4 F. Hoffmann-La Roche Ltd Company Profile and Main Business
10.18.5 F. Hoffmann-La Roche Ltd Recent Developments
10.19 Mylan N.V
10.19.1 Mylan N.V Company Information, Head Office, Market Area and Industry Position
10.19.2 Mylan N.V Perioral Dermatitis Treatment Models, Specifications and Application
10.19.3 Mylan N.V Perioral Dermatitis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.19.4 Mylan N.V Company Profile and Main Business
10.19.5 Mylan N.V Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Perioral Dermatitis Treatment Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Perioral Dermatitis Treatment Market Restraints
Table 3. Perioral Dermatitis Treatment Market Trends
Table 4. Perioral Dermatitis Treatment Industry Policy
Table 5. Global Perioral Dermatitis Treatment Revenue by Company, 2018-2023, US$ million
Table 6. Global Perioral Dermatitis Treatment Revenue Market Share by Company, 2018-2023
Table 7. Global Perioral Dermatitis Treatment Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Perioral Dermatitis Treatment Sales Volume Market Share by Company, 2018-2023
Table 9. Global Perioral Dermatitis Treatment Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Perioral Dermatitis Treatment Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Perioral Dermatitis Treatment Mergers & Acquisitions, Expansion Plans
Table 12. Global Perioral Dermatitis Treatment Manufacturers Product Type
Table 13. China Perioral Dermatitis Treatment Revenue by Company, 2018-2023, US$ million
Table 14. China Perioral Dermatitis Treatment Revenue Market Share by Company, 2018-2023
Table 15. China Perioral Dermatitis Treatment Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Perioral Dermatitis Treatment Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Perioral Dermatitis Treatment Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Perioral Dermatitis Treatment Import & Export Trends
Table 19. Main Sources of China Perioral Dermatitis Treatment Import
Table 20. Export Destination of China Perioral Dermatitis Treatment
Table 21. Global Headquarters and Manufacturing Base of Perioral Dermatitis Treatment Manufacturers
Table 22. Global Major Manufacturers, Perioral Dermatitis Treatment Capacity Expansion and Future Plans
Table 23. Global Perioral Dermatitis Treatment Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Perioral Dermatitis Treatment Production by Region, 2018-2023, (K Units)
Table 25. Global Perioral Dermatitis Treatment Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Perioral Dermatitis Treatment Upstream (Raw Materials)
Table 27. Global Perioral Dermatitis Treatment Typical Customers
Table 28. Perioral Dermatitis Treatment Typical Distributors
Table 29. By Type, Global Perioral Dermatitis Treatment Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Perioral Dermatitis Treatment Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Perioral Dermatitis Treatment Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Perioral Dermatitis Treatment Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Perioral Dermatitis Treatment Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Perioral Dermatitis Treatment Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Perioral Dermatitis Treatment Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Perioral Dermatitis Treatment Revenue Market Share, 2018-2029
Table 37. By Country, Global Perioral Dermatitis Treatment Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Perioral Dermatitis Treatment Sales Volume Market Share, 2018-2029
Table 39. Novartis AG Company Information, Head Office, Market Area and Industry Position
Table 40. Novartis AG Perioral Dermatitis Treatment Models, Specifications and Application
Table 41. Novartis AG Perioral Dermatitis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Novartis AG Company Profile and Main Business
Table 43. Novartis AG Recent Developments
Table 44. AstraZeneca Company Information, Head Office, Market Area and Industry Position
Table 45. AstraZeneca Perioral Dermatitis Treatment Models, Specifications and Application
Table 46. AstraZeneca Perioral Dermatitis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. AstraZeneca Company Profile and Main Business
Table 48. AstraZeneca Recent Developments
Table 49. Merck & Co., Inc Company Information, Head Office, Market Area and Industry Position
Table 50. Merck & Co., Inc Perioral Dermatitis Treatment Models, Specifications and Application
Table 51. Merck & Co., Inc Perioral Dermatitis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Merck & Co., Inc Company Profile and Main Business
Table 53. Merck & Co., Inc Recent Developments
Table 54. Sumitomo Corporation Company Information, Head Office, Market Area and Industry Position
Table 55. Sumitomo Corporation Perioral Dermatitis Treatment Models, Specifications and Application
Table 56. Sumitomo Corporation Perioral Dermatitis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Sumitomo Corporation Company Profile and Main Business
Table 58. Sumitomo Corporation Recent Developments
Table 59. LEO Pharma A/S Company Information, Head Office, Market Area and Industry Position
Table 60. LEO Pharma A/S Perioral Dermatitis Treatment Models, Specifications and Application
Table 61. LEO Pharma A/S Perioral Dermatitis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. LEO Pharma A/S Company Profile and Main Business
Table 63. LEO Pharma A/S Recent Developments
Table 64. Cipla Inc Company Information, Head Office, Market Area and Industry Position
Table 65. Cipla Inc Perioral Dermatitis Treatment Models, Specifications and Application
Table 66. Cipla Inc Perioral Dermatitis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Cipla Inc Company Profile and Main Business
Table 68. Cipla Inc Recent Developments
Table 69. Lilly Company Information, Head Office, Market Area and Industry Position
Table 70. Lilly Perioral Dermatitis Treatment Models, Specifications and Application
Table 71. Lilly Perioral Dermatitis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Lilly Company Profile and Main Business
Table 73. Lilly Recent Developments
Table 74. Bayer AG Company Information, Head Office, Market Area and Industry Position
Table 75. Bayer AG Perioral Dermatitis Treatment Models, Specifications and Application
Table 76. Bayer AG Perioral Dermatitis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Bayer AG Company Profile and Main Business
Table 78. Bayer AG Recent Developments
Table 79. Abbott Company Information, Head Office, Market Area and Industry Position
Table 80. Abbott Perioral Dermatitis Treatment Models, Specifications and Application
Table 81. Abbott Perioral Dermatitis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Abbott Company Profile and Main Business
Table 83. Abbott Recent Developments
Table 84. Pfizer Inc Company Information, Head Office, Market Area and Industry Position
Table 85. Pfizer Inc Perioral Dermatitis Treatment Models, Specifications and Application
Table 86. Pfizer Inc Perioral Dermatitis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Pfizer Inc Company Profile and Main Business
Table 88. Pfizer Inc Recent Developments
Table 89. GSK plc Company Information, Head Office, Market Area and Industry Position
Table 90. GSK plc Perioral Dermatitis Treatment Models, Specifications and Application
Table 91. GSK plc Perioral Dermatitis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. GSK plc Company Profile and Main Business
Table 93. GSK plc Recent Developments
Table 94. Johnson & Johnson Private Limited Company Information, Head Office, Market Area and Industry Position
Table 95. Johnson & Johnson Private Limited Perioral Dermatitis Treatment Models, Specifications and Application
Table 96. Johnson & Johnson Private Limited Perioral Dermatitis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Johnson & Johnson Private Limited Company Profile and Main Business
Table 98. Johnson & Johnson Private Limited Recent Developments
Table 99. Teva Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position
Table 100. Teva Pharmaceutical Industries Ltd Perioral Dermatitis Treatment Models, Specifications and Application
Table 101. Teva Pharmaceutical Industries Ltd Perioral Dermatitis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Teva Pharmaceutical Industries Ltd Company Profile and Main Business
Table 103. Teva Pharmaceutical Industries Ltd Recent Developments
Table 104. Sun Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position
Table 105. Sun Pharmaceutical Industries Ltd Perioral Dermatitis Treatment Models, Specifications and Application
Table 106. Sun Pharmaceutical Industries Ltd Perioral Dermatitis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Sun Pharmaceutical Industries Ltd Company Profile and Main Business
Table 108. Sun Pharmaceutical Industries Ltd Recent Developments
Table 109. Aurobindo Pharma Company Information, Head Office, Market Area and Industry Position
Table 110. Aurobindo Pharma Perioral Dermatitis Treatment Models, Specifications and Application
Table 111. Aurobindo Pharma Perioral Dermatitis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Aurobindo Pharma Company Profile and Main Business
Table 113. Aurobindo Pharma Recent Developments
Table 114. Lupin Company Information, Head Office, Market Area and Industry Position
Table 115. Lupin Perioral Dermatitis Treatment Models, Specifications and Application
Table 116. Lupin Perioral Dermatitis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 117. Lupin Company Profile and Main Business
Table 118. Lupin Recent Developments
Table 119. Bausch Health Companies Inc Company Information, Head Office, Market Area and Industry Position
Table 120. Bausch Health Companies Inc Perioral Dermatitis Treatment Models, Specifications and Application
Table 121. Bausch Health Companies Inc Perioral Dermatitis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 122. Bausch Health Companies Inc Company Profile and Main Business
Table 123. Bausch Health Companies Inc Recent Developments
Table 124. F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area and Industry Position
Table 125. F. Hoffmann-La Roche Ltd Perioral Dermatitis Treatment Models, Specifications and Application
Table 126. F. Hoffmann-La Roche Ltd Perioral Dermatitis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 127. F. Hoffmann-La Roche Ltd Company Profile and Main Business
Table 128. F. Hoffmann-La Roche Ltd Recent Developments
Table 129. Mylan N.V Company Information, Head Office, Market Area and Industry Position
Table 130. Mylan N.V Perioral Dermatitis Treatment Models, Specifications and Application
Table 131. Mylan N.V Perioral Dermatitis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 132. Mylan N.V Company Profile and Main Business
Table 133. Mylan N.V Recent Developments
List of Figure
Figure 1. Perioral Dermatitis Treatment Picture
Figure 2. By Revenue, Global Perioral Dermatitis Treatment Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Perioral Dermatitis Treatment Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Perioral Dermatitis Treatment Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Perioral Dermatitis Treatment Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Perioral Dermatitis Treatment Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Perioral Dermatitis Treatment Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Perioral Dermatitis Treatment Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Perioral Dermatitis Treatment Share of Global Market, 2018-2029
Figure 10. Global Perioral Dermatitis Treatment Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Perioral Dermatitis Treatment Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Perioral Dermatitis Treatment Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Perioral Dermatitis Treatment Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Perioral Dermatitis Treatment Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Perioral Dermatitis Treatment Domestic VS Export, 2022
Figure 16. Global Perioral Dermatitis Treatment Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Perioral Dermatitis Treatment Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Perioral Dermatitis Treatment Production Market Share & Forecast by Region, 2018-2029
Figure 19. Perioral Dermatitis Treatment Industry Chain
Figure 20. Perioral Dermatitis Treatment Procurement Model
Figure 21. Perioral Dermatitis Treatment Sales Model
Figure 22. Perioral Dermatitis Treatment Sales Channels, Direct Sales and Distribution
Figure 23. Oral
Figure 24. Injection
Figure 25. External Use
Figure 26. By Type, Global Perioral Dermatitis Treatment Revenue, 2018-2029, US$ Million
Figure 27. By Type, Global Perioral Dermatitis Treatment Revenue Market Share, 2018-2029
Figure 28. By Type, Global Perioral Dermatitis Treatment Sales Volume, 2018-2029, (K Units)
Figure 29. By Type, Global Perioral Dermatitis Treatment Sales Volume Market Share, 2018-2029
Figure 30. By Type, Global Perioral Dermatitis Treatment Price, 2018-2029, (US$/Unit)
Figure 31. Retail Pharmacy
Figure 32. Online Pharmacies
Figure 33. Other
Figure 34. By Application, Global Perioral Dermatitis Treatment Revenue, 2018-2029, US$ Million
Figure 35. By Application, Global Perioral Dermatitis Treatment Revenue Market Share, 2018-2029
Figure 36. By Application, Global Perioral Dermatitis Treatment Sales Volume, 2018-2029, (K Units)
Figure 37. By Application, Global Perioral Dermatitis Treatment Sales Volume Market Share, 2018-2029
Figure 38. By Application, Global Perioral Dermatitis Treatment Price, 2018-2029, (US$/Unit)
Figure 39. By Region, Global Perioral Dermatitis Treatment Revenue Market Share, 2018-2029
Figure 40. By Region, Global Perioral Dermatitis Treatment Sales Volume Market Share, 2018-2029
Figure 41. North America Perioral Dermatitis Treatment Revenue & Forecasts, 2018-2029, US$ Million
Figure 42. By Country, North America Perioral Dermatitis Treatment Revenue Market Share, 2022
Figure 43. Europe Perioral Dermatitis Treatment Revenue & Forecasts, 2018-2029, US$ Million
Figure 44. By Country, Europe Perioral Dermatitis Treatment Revenue Market Share, 2022
Figure 45. Asia Pacific Perioral Dermatitis Treatment Revenue & Forecasts, 2018-2029, US$ Million
Figure 46. By Country/Region, Asia Pacific Perioral Dermatitis Treatment Revenue Market Share, 2022
Figure 47. South America Perioral Dermatitis Treatment Revenue & Forecasts, 2018-2029, US$ Million
Figure 48. By Country, South America Perioral Dermatitis Treatment Revenue Market Share, 2022
Figure 49. Middle East & Africa Perioral Dermatitis Treatment Revenue & Forecasts, 2018-2029, US$ Million
Figure 50. U.S. Perioral Dermatitis Treatment Sales Volume, 2018-2029, (K Units)
Figure 51. By Company, U.S. Perioral Dermatitis Treatment Market Share, 2022
Figure 52. By Type, U.S. Perioral Dermatitis Treatment Sales Volume Market Share, 2022 VS 2029
Figure 53. By Application, U.S. Perioral Dermatitis Treatment Sales Volume Market Share, 2022 VS 2029
Figure 54. Europe Perioral Dermatitis Treatment Sales Volume, 2018-2029, (K Units)
Figure 55. By Company, Europe Perioral Dermatitis Treatment Market Share, 2022
Figure 56. By Type, Europe Perioral Dermatitis Treatment Sales Volume Market Share, 2022 VS 2029
Figure 57. By Application, Europe Perioral Dermatitis Treatment Sales Volume Market Share, 2022 VS 2029
Figure 58. China Perioral Dermatitis Treatment Sales Volume, 2018-2029, (K Units)
Figure 59. By Company, China Perioral Dermatitis Treatment Market Share, 2022
Figure 60. By Type, China Perioral Dermatitis Treatment Sales Volume Market Share, 2022 VS 2029
Figure 61. By Application, China Perioral Dermatitis Treatment Sales Volume Market Share, 2022 VS 2029
Figure 62. Japan Perioral Dermatitis Treatment Sales Volume, 2018-2029, (K Units)
Figure 63. By Company, Japan Perioral Dermatitis Treatment Market Share, 2022
Figure 64. By Type, Japan Perioral Dermatitis Treatment Sales Volume Market Share, 2022 VS 2029
Figure 65. By Application, Japan Perioral Dermatitis Treatment Sales Volume Market Share, 2022 VS 2029
Figure 66. South Korea Perioral Dermatitis Treatment Sales Volume, 2018-2029, (K Units)
Figure 67. By Company, South Korea Perioral Dermatitis Treatment Market Share, 2022
Figure 68. By Type, South Korea Perioral Dermatitis Treatment Sales Volume Market Share, 2022 VS 2029
Figure 69. By Application, South Korea Perioral Dermatitis Treatment Sales Volume Market Share, 2022 VS 2029
Figure 70. Southeast Asia Perioral Dermatitis Treatment Sales Volume, 2018-2029, (K Units)
Figure 71. By Company, Southeast Asia Perioral Dermatitis Treatment Market Share, 2022
Figure 72. By Type, Southeast Asia Perioral Dermatitis Treatment Sales Volume Market Share, 2022 VS 2029
Figure 73. By Application, Southeast Asia Perioral Dermatitis Treatment Sales Volume Market Share, 2022 VS 2029
Figure 74. India Perioral Dermatitis Treatment Sales Volume, 2018-2029, (K Units)
Figure 75. By Company, India Perioral Dermatitis Treatment Market Share, 2022
Figure 76. By Type, India Perioral Dermatitis Treatment Sales Volume Market Share, 2022 VS 2029
Figure 77. By Application, India Perioral Dermatitis Treatment Sales Volume Market Share, 2022 VS 2029
Figure 78. Middle East & Asia Perioral Dermatitis Treatment Sales Volume, 2018-2029, (K Units)
Figure 79. By Company, Middle East & Asia Perioral Dermatitis Treatment Market Share, 2022
Figure 80. By Type, Middle East & Asia Perioral Dermatitis Treatment Sales Volume Market Share, 2022 VS 2029
Figure 81. By Application, Middle East & Asia Perioral Dermatitis Treatment Sales Volume Market Share, 2022 VS 2029
Figure 82. Research Methodology
Figure 83. Breakdown of Primary Interviews
Figure 84. Bottom-up Approaches
Figure 85. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|